GRADALIS
Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil, our proprietary immunotherapy platform in multiple advanced cancer indications with the lead program for the treatment of patients with Ewing's sarcoma.
GRADALIS
Industry:
Biotechnology Health Diagnostics Manufacturing
Founded:
2003-01-01
Address:
Carrollton, Texas, United States
Country:
United States
Website Url:
http://www.gradalisinc.com
Total Employee:
11+
Status:
Active
Contact:
214-442-8100
Total Funding:
67.94 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics
Similar Organizations
Advanced Enzymes
Advanced Enzyme is a research driven company manufacturing enzymes and probiotics and dedicated to marketing eco-safe solutions.
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Alpheus Medical
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.
Alpine Biomed
Alpine Biomed is a designs and manufactures diagnostic equipment and accessories for the gastroenterology and neurology markets.
Amnos
Amnos is engages in developing, manufacturing and selling dried human amnion.
Arrayit
Arrayit is a company manufacturing proprietary life science technologies and consumables for disease prevention, treatment, and cure.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Cellibre
Cellibre turns cells into specialized, sustainable factories for the manufacture of globally significant products at scale.
Copan Diagnostics
Copan Diagnostics is a manufacturer of transport systems for potentially pathogenic biological vectors, such as bacteria and viruses.
Elemental Enzymes
Elemental Enzymes is an enzyme manufacturer based in Columbia, MO.
enzymatics
Enzymatics is an independent, ISO 13485:2003 certified OEM manufacturer of enzymes that brings to the marketplace a unique, quality
Epigenomics
Epigenomics is a molecular diagnostics company developing and manufacturing a pipeline of products for the diagnosis of cancer.
Exact Sciences
Exact Sciences is the developer and manufacturer of Cologuard, a non-invasive screening test for the early detection of colorectal cancer.
Gen9
Gen9 provides gene synthesis technology that enables the high-throughput, automated production of DNA constructs.
InnovaPrep
InnovaPrep is engaged in product development, manufacturing, sales, service, and related out-licensing of collection of novel technologies.
Innovita Biological Technology
Innovita Biological Technology provides R&D, manufacturing, marketing and after-sales service of In-vitro diagnostic tests.
Living Ink Technologies
Living Ink Technologies is developing bio-based pigments for ink
Redbud Labs
Redbud Labs develops and manufactures MEMS and microfluidics technologies for the life science industry.
Rentschler Biopharma SE
Rentschler Biopharma SE is a global full-service contract manufacturer with more than 35 years of experience.
Rubi Laboratories
Rubi Laboratories develops technology that turns carbon emissions into carbon-negative textiles.
Simcere Pharma
Simcere Pharma is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market.
TerraVerdae BioWorks
TerraVerdae BioWorks is an innovative green materials and chemicals company dedicated to the development of sustainable products.
Tidal Vision
Tidal Vision manufacturers chitosan-based bimolecular solutions for some of humanity's greatest chemistry and pollution challenges.
Tokiwa Bio
Tokiwa Bio is a manufacturing and development company.
Tornado Spectral Systems
Tornado Spectral Systems designs, manufactures, and sells dispersive optical spectrometers primarily for Raman spectroscopy.
UPPER
UPPER is a biomedicine manufacturing company.
ViewRay
ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.
Current Advisors List
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-02 | Gradalis Appoints Steven Engle as Chief Executive Officer |
Official Site Inspections
http://www.gradalisinc.com Semrush global rank: 5.64 M Semrush visits lastest month: 1.49 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Gradalis"
Company | Gradalis®
Monk is a co-founder of the GOG-Partners Foundation®, a nonprofit organization committed to advancing clinical and scientific research in the field of gynecologic malignancies. The organization was instrumental in establishing a national …See details»
Gradalis® — Immunotherapy
Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer. We are developing Vigil, our proprietary immunotherapy platform in multiple advanced …See details»
Gradalis - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 214-442-8100 Gradalis is a late stage biotechnology company focused on the development and commercialization of novel personalized therapeutics to treat cancer.See details»
Gradalis, Inc. Management Team | Org Chart - RocketReach
Gradalis, Inc. employs 41 employees. The Gradalis, Inc. management team includes David Shanahan (Chief Executive Officer and Chairman of the Board), Ernie Bognar (Chief …See details»
Gradalis Company Profile 2024: Valuation, Funding
Gradalis General Information Description. Developer of drugs, vaccines, tools and diagnostics intended to treat cancer. The company's products specialize in the development and commercialization of novel personalized therapeutics to …See details»
Gradalis, Inc. - LinkedIn
Gradalis, Inc. | 1,036 followers on LinkedIn. Leading a new way to fight cancer | Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications ...See details»
Gradalis, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Gradalis Contact Mark Early (214) 442-8161 [email protected] LifeSci Advisors Contact Joyce Allaire +1 (617) 435-6602 [email protected]. Phase 2 Clinical Result ... The …See details»
Gradalis, Inc. Company Profile | Carrollton, TX | Competitors ...
Find company research, competitor information, contact details & financial data for Gradalis, Inc. of Carrollton, TX. Get the latest business insights from Dun & Bradstreet.See details»
Gradalis Company Profile - Office Locations, Competitors ... - Craft
Gradalis has 5 employees at their 1 location and $67.9 m in total funding,. See insights on Gradalis including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Gradalis - Overview, News & Similar companies | ZoomInfo.com
Mar 29, 2023 Who is Gradalis. Gradalis is a late-stage clinical biotechnology company developing immunotherapies for multiple cancer indications including an upcoming Phase 3 re …See details»
Gradalis Company Profile -Sales, Contacts, Competitors – Buzzfile
Gradalis is located in Carrollton, Texas. This organization primarily operates in the Vaccines business / industry within the Chemicals and Allied Products sector. This organization has …See details»
Careers - Gradalis®
Gradalis is an equal opportunity employer and does not discriminate with regard to age, race, color, religion, sex, disability, genetic information, national origin, veteran status or any other …See details»
Gradalis Awarded $9.9 Million Grant From the Cancer Prevention …
DALLAS, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Gradalis, Inc., a leader in the development of personalized anti-cancer cellular therapies for patients with solid tumors, announced today that …See details»
Gradalis® Announces Initiation of Phase 3 Study of Vigil ... - LinkedIn
Aug 28, 2018 PRESS RELEASE Gradalis® Announces Initiation of Phase 3 Study of Vigil™ in Ewing’s sarcoma – The open-label trial will measure progression free survival of participants …See details»
Gradalis Awarded $9.9 Million Grant From the Cancer
Nov 16, 2023 [email protected]. LifeSci Advisors Contact Joyce Allaire +1 (617) 435-6602 [email protected] ...See details»
Clinical Trials | Gradalis®
Clinical trials are research investigations in which people volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various diseases or …See details»
Gradalis Receives Clearance to Begin Pivotal Phase 3 Clinical Trial …
Dec 21, 2022 When combined, these are a powerful Trifecta of anti-cancer activities, potentially eliminating even the elusive metastatic cells. Visit www.gradalisinc.com for more information. …See details»
Patients | Gradalis®
At Gradalis, we believe patients should be involved with their therapy to the degree that they are comfortable. To that end, we have provided several links to sites that may serve them.See details»
Gradalis’ GRAD1405 bi-shRNAi Candidate First to Show
Jan 4, 2024 [email protected]. LifeSci Advisors Contact Joyce Allaire +1 (617) 435-6602 [email protected] ...See details»
News - Gradalis®
Get the latest clinical and R&D news. Gradalis Announces Publication of Phase 2b VITAL trial of Vigil® demonstrating RFS and OS advantage in women with first-line platinum-responsive …See details»